| Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders S Ducharme, A Dols, R Laforce, E Devenney, F Kumfor, J Van Den Stock, ... Brain 143 (6), 1632-1650, 2020 | 276 | 2020 |
| Alzheimer’s disease: clinical update on epidemiology, pathophysiology and diagnosis D Eratne, SM Loi, S Farrand, W Kelso, D Velakoulis, JCL Looi Australasian psychiatry 26 (4), 347-357, 2018 | 256 | 2018 |
| Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer's disease K Dhiman, VB Gupta, VL Villemagne, D Eratne, PL Graham, C Fowler, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 12 (1 …, 2020 | 96 | 2020 |
| Time to diagnosis in younger-onset dementia and the impact of a specialist diagnostic service SM Loi, AMY Goh, R Mocellin, CB Malpas, S Parker, D Eratne, S Farrand, ... International Psychogeriatrics 34 (4), 367-375, 2022 | 74 | 2022 |
| A pilot study of the utility of cerebrospinal fluid neurofilament light chain in differentiating neurodegenerative from psychiatric disorders: A ‘C-reactive protein’for … D Eratne, SM Loi, N Walia, S Farrand, QX Li, S Varghese, M Walterfang, ... Australian & New Zealand Journal of Psychiatry 54 (1), 57-67, 2020 | 54 | 2020 |
| Psychiatric and cognitive symptoms associated with Niemann-Pick type C disease: neurobiology and management T Rego, S Farrand, AMY Goh, D Eratne, W Kelso, S Mangelsdorf, ... CNS drugs 33, 125-142, 2019 | 44 | 2019 |
| Cerebrospinal fluid neurofilament light chain differentiates primary psychiatric disorders from rapidly progressive, Alzheimer's disease and frontotemporal disorders in … D Eratne, SM Loi, QX Li, C Stehmann, CB Malpas, A Santillo, S Janelidze, ... Alzheimer's & Dementia 18 (11), 2218-2233, 2022 | 36 | 2022 |
| Alzheimer disease: non-pharmacological and pharmacological management of cognition and neuropsychiatric symptoms SM Loi, D Eratne, W Kelso, D Velakoulis, JCL Looi Australasian Psychiatry 26 (4), 358-365, 2018 | 36 | 2018 |
| The diagnostic challenge of young-onset dementia syndromes and primary psychiatric diseases: results from a retrospective 20-year cross-sectional study P Tsoukra, D Velakoulis, P Wibawa, CB Malpas, M Walterfang, A Evans, ... The Journal of Neuropsychiatry and Clinical Neurosciences 34 (1), 44-52, 2022 | 33 | 2022 |
| A 10 year retrospective cohort study of inpatients with younger‐onset dementia SM Loi, D Eratne, AMY Goh, P Wibawa, S Farrand, W Kelso, A Evans, ... International journal of geriatric psychiatry 36 (2), 294-301, 2021 | 24 | 2021 |
| NCKAP1 disruptive variants lead to a neurodevelopmental disorder with core features of autism H Guo, Q Zhang, R Dai, B Yu, K Hoekzema, J Tan, S Tan, X Jia, ... The American Journal of Human Genetics 107 (5), 963-976, 2020 | 24 | 2020 |
| The clinical utility of exome sequencing and extended bioinformatic analyses in adolescents and adults with a broad range of neurological phenotypes: an Australian perspective D Eratne, A Schneider, E Lynch, M Martyn, D Velakoulis, M Fahey, ... Journal of the neurological sciences 420, 117260, 2021 | 23 | 2021 |
| Plasma neurofilament light chain protein is not increased in treatment-resistant schizophrenia and first-degree relatives D Eratne, S Janelidze, CB Malpas, S Loi, M Walterfang, A Merritt, I Diouf, ... Australian & New Zealand Journal of Psychiatry 56 (10), 1295-1305, 2022 | 20 | 2022 |
| Cerebrospinal fluid neurofilament light chain is elevated in Niemann–Pick type C compared to psychiatric disorders and healthy controls and may be a marker of treatment response D Eratne, SM Loi, QX Li, S Varghese, A McGlade, S Collins, CL Masters, ... Australian & New Zealand Journal of Psychiatry 54 (6), 648-649, 2020 | 20 | 2020 |
| Plasma neurofilament light in behavioural variant frontotemporal dementia compared to mood and psychotic disorders D Eratne, M Kang, C Malpas, S Simpson-Yap, C Lewis, C Dang, J Grewal, ... Australian & New Zealand Journal of Psychiatry 58 (1), 70-81, 2024 | 19 | 2024 |
| Cerebrospinal fluid neurofilament light chain differentiates behavioural variant frontotemporal dementia progressors from non-progressors D Eratne, M Keem, C Lewis, M Kang, M Walterfang, S Farrand, S Loi, ... Journal of the Neurological Sciences 442, 120439, 2022 | 15 | 2022 |
| Plasma neurofilament light chain and clinical diagnosis in frontotemporal dementia syndromes S Ooi, SK Patel, D Eratne, C Kyndt, N Reidy, C Lewis, SCM Lee, D Darby, ... Journal of Alzheimer’s Disease 89 (4), 1221-1231, 2022 | 15 | 2022 |
| Mortality in dementia is predicted by older age of onset and cognitive presentation SM Loi, P Tsoukra, Z Chen, P Wibawa, T Mijuskovic, D Eratne, ... Australian & New Zealand Journal of Psychiatry 56 (7), 852-861, 2022 | 14 | 2022 |
| Clinical impact of whole-genome sequencing in patients with early-onset dementia AJ Huq, B Thompson, MF Bennett, A Bournazos, S Bommireddipalli, ... Journal of Neurology, Neurosurgery & Psychiatry 93 (11), 1181-1189, 2022 | 11 | 2022 |
| A phase 1b open‐label study of sodium selenate as a disease‐modifying treatment for possible behavioral variant frontotemporal dementia L Vivash, CB Malpas, C Meletis, M Gollant, D Eratne, QX Li, S McDonald, ... Alzheimer's & Dementia: Translational Research & Clinical Interventions 8 (1 …, 2022 | 10 | 2022 |
Dennis VelakoulisRoyal Melbourne Hospital and University of MelbourneVerified email at mh.org.au
